Novartis (NVS) Tops Q1 EPS by 1c

Novartis (NYSE: NVS) reported Q1 EPS of $1.13, $0.01 better than the analyst estimate of $1.12. Revenue for the quarter came in at $11.5 billion versus the consensus estimate of $11.65 billion.

Novartis confirmed FY17 outlook.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI